Search research articles
Contact Us
Filters
Showing results (71-80 of 105) with videos related to
Page
of 11
Sort By:
Journal of Rehabilitation Research and Development
|
February 14, 2006
Clinical management of tinnitus using a "progressive intervention" approach
James A Henry, Martin A Schechter, Carl L Loovis, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
December 20, 2022
Effect of OTX-101 in Patients with Dry Eye Disease at Day 14 of Treatment: Ocular Surface Endpoint Results from the Phase 2b/3 Clinical Trial
Barry A Schechter, Maitee Urbieta, Jason Bacharach, et al.
Ophthalmology
|
April 10, 2019
A Phase 3, Randomized, Double-Masked Study of OTX-101 Ophthalmic Solution 0.09% in the Treatment of Dry Eye Disease
Damien F Goldberg, Ranjan P Malhotra, Barry A Schechter, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|
November 26, 2013
Outcomes after implantable left ventricular assist device replacement procedures
Matthew A Schechter, Mani A Daneshmand, Chetan B Patel, et al.
The Annals of Thoracic Surgery
|
September 20, 2015
Changes in Risk Profile and Outcomes of Patients Undergoing Surgical Aortic Valve Replacement From the Pre- to Post-Transcatheter Aortic Valve Replacement Eras
Brian R Englum, Asvin M Ganapathi, Matthew A Schechter, et al.
Nature
|
October 26, 2000
Prototype systems for rechargeable magnesium batteries
D Aurbach, Z Lu, A Schechter, et al.
Annals of the New York Academy of Sciences
|
January 26, 1999
There is binding of collagen IV to beta 1 integrin during early skin basement membrane assembly
R Fleischmajer, J S Perlish, E D MacDonald, et al.
American Journal of Otolaryngology
|
May 1, 1984
Detection of aminoglycoside ototoxicity by high-frequency auditory evaluation: selected case studies
S A Fausti, B Z Rappaport, M A Schechter, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
October 17, 2018
A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease
Joseph Tauber, Barry A Schechter, Jason Bacharach, et al.
Cornea
|
December 18, 2004
Corneal melt after amniotic membrane transplant
Barry A Schechter, William J Rand, Robert S Nagler, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 105) with videos related to
Sort By:
Page
of 11
Journal of Rehabilitation Research and Development
|
February 14, 2006
Clinical management of tinnitus using a "progressive intervention" approach
James A Henry, Martin A Schechter, Carl L Loovis, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
December 20, 2022
Effect of OTX-101 in Patients with Dry Eye Disease at Day 14 of Treatment: Ocular Surface Endpoint Results from the Phase 2b/3 Clinical Trial
Barry A Schechter, Maitee Urbieta, Jason Bacharach, et al.
Ophthalmology
|
April 10, 2019
A Phase 3, Randomized, Double-Masked Study of OTX-101 Ophthalmic Solution 0.09% in the Treatment of Dry Eye Disease
Damien F Goldberg, Ranjan P Malhotra, Barry A Schechter, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|
November 26, 2013
Outcomes after implantable left ventricular assist device replacement procedures
Matthew A Schechter, Mani A Daneshmand, Chetan B Patel, et al.
The Annals of Thoracic Surgery
|
September 20, 2015
Changes in Risk Profile and Outcomes of Patients Undergoing Surgical Aortic Valve Replacement From the Pre- to Post-Transcatheter Aortic Valve Replacement Eras
Brian R Englum, Asvin M Ganapathi, Matthew A Schechter, et al.
Nature
|
October 26, 2000
Prototype systems for rechargeable magnesium batteries
D Aurbach, Z Lu, A Schechter, et al.
Annals of the New York Academy of Sciences
|
January 26, 1999
There is binding of collagen IV to beta 1 integrin during early skin basement membrane assembly
R Fleischmajer, J S Perlish, E D MacDonald, et al.
American Journal of Otolaryngology
|
May 1, 1984
Detection of aminoglycoside ototoxicity by high-frequency auditory evaluation: selected case studies
S A Fausti, B Z Rappaport, M A Schechter, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
October 17, 2018
A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease
Joseph Tauber, Barry A Schechter, Jason Bacharach, et al.
Cornea
|
December 18, 2004
Corneal melt after amniotic membrane transplant
Barry A Schechter, William J Rand, Robert S Nagler, et al.
Page
of 11